Shan Dong Kexing Bioproducts Co (SHSE:688136) Beneish M-Score: -2.23 (As of Jul. 12, 2026)


SHSE:688136 Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
44 GF Score
Price ¥20.96
GF Value ¥23.98
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shan Dong Kexing Bioproducts Co Beneish M-Score?

Shan Dong Kexing Bioproducts Co SHSE:688136 -2.19% 44 Beneish M-Score is -2.23 as of Jul. 12, 2026. GuruFocus rates SHSE:688136 with a GF Score™ of 44/100 and a GF Value™ of ¥23.98 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 825 Biotechnology companies, Shan Dong Kexing Bioproducts Co ranks worse than 54.79% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.23 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's Beneish M-Score or its related term are showing as below:

SHSE:688136' s Beneish M-Score Range Over the Past 10 Years
Min: -2.74   Med: -2.28   Max: -1.58
Current: -2.23

During the past 9 years, the highest Beneish M-Score of Shan Dong Kexing Bioproducts Co was -1.58. The lowest was -2.74. And the median was -2.28.


Shan Dong Kexing Bioproducts Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shan Dong Kexing Bioproducts Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shan Dong Kexing Bioproducts Co Beneish M-Score Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -1.89 -2.39 -2.69 -2.00 -2.06

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.12 -2.24 -1.85 -2.06 -2.23

SHSE:688136 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shan Dong Kexing Bioproducts Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Beneish M-Score falls into.


SHSE:688136
44GF Score
Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shan Dong Kexing Bioproducts Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shan Dong Kexing Bioproducts Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0715+0.528 * 1.0993+0.404 * 1.0865+0.892 * 1.0437+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9215+4.679 * 0.012765-0.327 * 1.0446
=-2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥680 Mil.
Revenue was 280.525 + 386.389 + 447.174 + 346.905 = ¥1,461 Mil.
Gross Profit was 164.527 + 242.82 + 284.026 + 205.227 = ¥897 Mil.
Total Current Assets was ¥1,553 Mil.
Total Assets was ¥3,490 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,094 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥477 Mil.
Total Current Liabilities was ¥1,037 Mil.
Long-Term Debt & Capital Lease Obligation was ¥693 Mil.
Net Income was -17.937 + 44.305 + 30.919 + 54.767 = ¥112 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 6.917 + 93.286 + -37.056 + 4.353 = ¥68 Mil.
Total Receivables was ¥608 Mil.
Revenue was 353.559 + 368.669 + 278.361 + 399.231 = ¥1,400 Mil.
Gross Profit was 239.981 + 241.091 + 182.881 + 280.446 = ¥944 Mil.
Total Current Assets was ¥1,324 Mil.
Total Assets was ¥3,194 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,160 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥495 Mil.
Total Current Liabilities was ¥882 Mil.
Long-Term Debt & Capital Lease Obligation was ¥633 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(679.532 / 1460.993) / (607.629 / 1399.82)
=0.465117 / 0.434077
=1.0715

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(944.399 / 1399.82) / (896.6 / 1460.993)
=0.674657 / 0.613692
=1.0993

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1553.202 + 1094.126) / 3490.438) / (1 - (1323.938 + 1159.762) / 3193.719)
=0.241548 / 0.222317
=1.0865

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1460.993 / 1399.82
=1.0437

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1159.762)) / (0 / (0 + 1094.126))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(476.539 / 1460.993) / (495.489 / 1399.82)
=0.326175 / 0.353966
=0.9215

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((693.375 + 1037.15) / 3490.438) / ((633.486 + 882.261) / 3193.719)
=0.49579 / 0.474602
=1.0446

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(112.054 - 0 - 67.5) / 3490.438
=0.012765

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shan Dong Kexing Bioproducts Co has a M-score of -2.23 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.23 mean?
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a Beneish M-Score of -2.23 as of Jul. 12, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. According to the industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #452 out of 825 companies in the Biotechnology industry, placing it in the top 54.8%.
Is Shan Dong Kexing Bioproducts Co's Beneish M-Score too high?
Shan Dong Kexing Bioproducts Co's current Beneish M-Score is -2.23. Based on the distribution chart, Shan Dong Kexing Bioproducts Co ranks #452 out of 825 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #452 out of 825 companies for Beneish M-Score. This places Shan Dong Kexing Bioproducts Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. Shan Dong Kexing Bioproducts Co's current Beneish M-Score is -2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.98, compared to a current price of ¥20.96 — trading 12.6% below its estimated fair value. The current Beneish M-Score is -2.23. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current Beneish M-Score is -2.23 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?

Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued. The current stock price of ¥20.96 is trading 12.6% below its estimated GF Value™ of ¥23.98. GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.

Key valuation signals for SHSE:688136:

  • Beneish M-Score: -2.23
  • GF Value™: ¥23.98 vs. price of ¥20.96 (12.6% below fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shan Dong Kexing Bioproducts Co Business Description

Address No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
44GF Score

Get the complete analysis for SHSE:688136

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.96
Price
¥23.98
GF Value